Front Line Genomics invites you to their event
About this event
Nearly all the body’s functions are based on cellular heterogeneity – from complex neurobiological functions, to the development of disease from an individual tumour cell – single cell technologies can give incredible insights into health and disease.
Despite single cell analysis already playing a major role in biological research, challenges remain to make the best use out of the technologies.
Join us for our Single Cell ONLINE – a virtual 4-part series where we dive further into the technology that is giving insights into cellular heterogeneity.
Each session will be one hour long and will be at 3pm BST/ 4pm CET/ 10am ET
** Please note: By signing up to one webinar in the series you automatically get registered to all of the sessions in the series**
With developments in technical ability to separate single cells from each other and the falling cost of sequencing, single cell analysis can transform our understanding of diseases at the cellular level.
As technology is constantly evolving, it is difficult for anyone to stay on top of what the latest technology does, whether it is right for them or their research question. So how, and where, should we invest for the next era of single cell studies?
Join us for this interactive global panel discussion featuring world leaders in the single cell and genomics field, as we explore the current state of single cell studies and what is on the horizon.
Speakers:
Stefania Giacomello, Group Leader, SciLifeLab
Christophe Fleury, Science and Technology Advisor, 10x Genomics
Florian Baumgartner, Senior Product Manager, Visium Spatial Informatics, 10x Genomics
Wai Long Tam, Manager Technology Innovation Lab, Flemish Institute for Biotechnology (VIB)
Carlo Sara Frigerio, Programme leader, UK Dementia Research Institute, University College London
For this three-part webinar, leading experts in genomics will share the latest breakthroughs in genomic, transcriptomic and proteomic analysis at the single-cell level. Workflow improvements in sample preparation, biochemistry and data analysis will be discussed. Additionally, presenters will highlight recent success stories targeting fundamental questions in biology as well as addressing clinical demands in the emerging field of precision medicine.
Join us for these three insightful presentations:
"scRapid: Faster Single-cell RNA Sequencing with Unparalleled Sensitivity" - Simone Picelli, Head of the Single-cell Genomics Platform, Institute of Molecular and Clinical Ophthalmology Basel
"Dispensing Technologies for Highly Efficient Single-cell Analysis Workflows" - Julian Riba, Chief Scientific Officer, cytena
"Single-cell Proteomic and Transcriptomic Analysis of Macrophage Polarization" - Nikolai Slavov, Allen Distinguished Investigator, Assistant Professor, Northeastern University
Integrative single cell analysis provides a unique set of challenges. With single cell already playing an important role for drug discovery, join us as we discuss the lessons learned from global pharma companies as we implement, refine protocols and apply the technology across the R&D pipeline.
Join us for three insightful presentations:
“Pooled CRISPR screening with single cell RNA seq read-out in cancer cells” – Antoine De Weck, Team Lead, Oncology Data Science, Novartis
“Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology”– Dinesh Kumar, Principal Scientist, Sanofi
"Leveraging single-cell analysis to unravel treatment resistance mechanisms and monitor minimal residual disease" - Kelly Kaihara, Ph.D., Applications Manager, MissionBio
Using population genetics and single cell sequencing to discover cell-type specific genetic risk for disease, and drug efficacy - Joseph Powell, Director, Garvan-Weizmann Centre for Cellular Genomics
Genetics of single-cell gene expression during T cell activation - Blagoje Sosik, Postdoctoral Fellow, Immune genomics group, Wellcome Sanger
From clones to subsets: using transcriptomics to characterise the CD8 T cell response to Checkpoint Immunotherapy - Benjamin Fairfax, Principal Investigator, University of Oxford and Robert Watson, Academic Clinical Fellow, Oxford University Hospital NHS Foundation Trust
Hosted by
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.
